305 related articles for article (PubMed ID: 18202164)
21. Malignant pleural mesothelioma: surgical management in 285 patients.
Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
[TBL] [Abstract][Full Text] [Related]
22. Incidence of malignant pleural mesothelioma in coastal and continental Croatia: epidemiological study.
Curin K; Sarić M; Strnad M
Croat Med J; 2002 Aug; 43(4):498-502. PubMed ID: 12187531
[TBL] [Abstract][Full Text] [Related]
23. [Mesothelioma of the pleura in the Province of Trieste].
Bianchi C; Bianchi T; Tommasi M
Med Lav; 2007; 98(5):374-80. PubMed ID: 17907531
[TBL] [Abstract][Full Text] [Related]
24. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.
Fusco V; Ardizzoni A; Merlo F; Cinquegrana A; Faravelli B; De Palma M; Chessa L; Nicolò G; Serra M; Capaccio A
Anticancer Res; 1993; 13(3):683-9. PubMed ID: 8317897
[TBL] [Abstract][Full Text] [Related]
25. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma.
Halstead JC; Lim E; Venkateswaran RM; Charman SC; Goddard M; Ritchie AJ
Eur J Surg Oncol; 2005 Apr; 31(3):314-20. PubMed ID: 15780570
[TBL] [Abstract][Full Text] [Related]
26. A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results.
Pass HI; Brewer GJ; Dick R; Carbone M; Merajver S
Ann Thorac Surg; 2008 Aug; 86(2):383-9; discussion 390. PubMed ID: 18640301
[TBL] [Abstract][Full Text] [Related]
27. [Treatment strategy in pleural mesothelioma].
Schirren J; Muley T; Schneider P; Trainer C; Bülzebruck H; Dienemann H; Vogt-Moykopf I
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():498-506. PubMed ID: 9931667
[TBL] [Abstract][Full Text] [Related]
28. The role of radiotherapy in the treatment of malignant pleural mesothelioma.
Waite K; Gilligan D
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):182-7. PubMed ID: 17359904
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues.
Davies HE; Musk AW; Lee YC
Curr Opin Pulm Med; 2008 Jul; 14(4):326-30. PubMed ID: 18520267
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors in cases of diffuse malignant pleural mesothelioma].
Umeki S; Kawai S; Hino J; Adachi M; Yagi S; Soejima R
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jul; 27(7):768-76. PubMed ID: 2810965
[TBL] [Abstract][Full Text] [Related]
31. Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.
Bottomley A; Coens C; Efficace F; Gaafar R; Manegold C; Burgers S; Vincent M; Legrand C; van Meerbeeck JP;
J Clin Oncol; 2007 Dec; 25(36):5770-6. PubMed ID: 18089874
[TBL] [Abstract][Full Text] [Related]
32. [Malignant pleural mesotheliomas].
Mercurio S; Poleri C; Carassai M; Abdala O; Lombardi D; Levy R; Rojas O; Morero J; Rosenberg M
Medicina (B Aires); 1998; 58(6):699-706. PubMed ID: 10347962
[TBL] [Abstract][Full Text] [Related]
33. Population-based survival for malignant mesothelioma after introduction of novel chemotherapy.
Damhuis RA; Schroten C; Burgers JA
Eur Respir J; 2012 Jul; 40(1):185-9. PubMed ID: 22135283
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
[TBL] [Abstract][Full Text] [Related]
35. Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?
Li L; Razak AR; Hughes A
Lung Cancer; 2009 May; 64(2):207-10. PubMed ID: 18926592
[TBL] [Abstract][Full Text] [Related]
36. Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis.
Baud M; Strano S; Dechartres A; Jouni R; Triponez F; Chouaid C; Forgez P; Damotte D; Roche N; Régnard JF; Alifano M
J Thorac Cardiovasc Surg; 2013 May; 145(5):1305-11. PubMed ID: 23072703
[TBL] [Abstract][Full Text] [Related]
37. Post-irradiation malignant mesothelioma.
Cavazza A; Travis LB; Travis WD; Wolfe JT; Foo ML; Gillespie DJ; Weidner N; Colby TV
Cancer; 1996 Apr; 77(7):1379-85. PubMed ID: 8608519
[TBL] [Abstract][Full Text] [Related]
38. Malignant pleural mesothelioma. Report of 19 cases.
Shearin JC; Jackson D
J Thorac Cardiovasc Surg; 1976 Apr; 71(4):621-7. PubMed ID: 1263545
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in malignant pleural mesothelioma: role of talc pleurodesis.
Al-Alao BS; Parissis H; Rychlik IJ; Graham A; McGuigan J
Asian Cardiovasc Thorac Ann; 2012 Aug; 20(4):443-9. PubMed ID: 22879552
[TBL] [Abstract][Full Text] [Related]
40. [Malignant mesothelioma: study of prognostic factors in a series of 188 cases].
Viallat JR; Boutin C; Rey F; Astoul P; Farisse P
Arch Anat Cytol Pathol; 1993; 41(5-6):205-11. PubMed ID: 8135581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
